BiomX Inc.

AMEX: PHGE · Healthcare · Biotechnology

PublicHQ Dover, CIK 0001739174Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH 26DQ —GM —SS 34

v0.1 · 35/100 weight · pillars only

↑ balance-sheet leverage, workforce scale · ↓ return on equity, return on assets

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$36.2M

Employees

Market cap

$508.3k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$36.2M-$36.2M2025

Operating income-$41.5M-$41.5M2025

Total assets$5.8M$5.8M2025

Liabilities$871.0k$871.0k2019

Equity-$1.3M-$1.3M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

BiomX Inc. earned -$36.2M in FY2025 net income.

Peers · Healthcare

Doseology Sciences Inc.40D Therapeutic Solutions International, Inc.——Bluejay Diagnostics, Inc.34D Mednow Inc.——

Key facts

CEOMarina Wolfson

SectorHealthcare

IndustryBiotechnology

HeadquartersDover, null

ExchangeAMEX: PHGE

Employees20

IPO date2019-03-13

Latest filings

8-K2026-07-10 8-K2026-07-02 8-K2026-06-26 8-K2026-06-18 8-K2026-06-12 DEF 14A2026-06-08 8-K2026-06-05 8-K2026-05-28

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.